Primazole

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Primazole

Property Description
Active Ingredients Sulphamethoxazole, Trimethoprim
Form Oral Tablet, Oral Suspension
Pharmacological Class Combination Antibacterial (Sulfonamide and Dihydrofolate Reductase Inhibitor)
General Purpose Systemic Anti-infective
Origin Synthetic

Primazole is a synthetic combination antibiotic that addresses various infections caused by susceptible bacterial organisms and is internationally recognized by the generic name Co-trimoxazole or TMP-SMX. This prescription medicine is firmly classified within two distinct pharmacological groups: the sulfonamide antibiotics and the dihydrofolate reductase inhibitors. It is available for oral use in multiple high-level pharmaceutical preparations, including the tablet and suspension forms.


What is the Composition and Class of Primazole?

Primazole is fundamentally a fixed-dose combination product containing two essential, co-acting active ingredients: Sulphamethoxazole and Trimethoprim. Co-trimoxazole is utilized for its role in microbial management. The combination has broad utility against a range of microbial organisms and is classified as an essential medicine. This indicates that the medicine is considered a necessary tool for public health systems. The final preparation combines these two therapeutic components, along with necessary pharmaceutical excipients, to create the final, ingestible dosage form.


Why is Primazole Classified as a Synergistic Antibacterial?

The classification as a synergistic antibacterial is attributed to the increase in efficacy achieved by combining Sulphamethoxazole and Trimethoprim compared to using either agent individually. The synergy is rooted in the strategic anti-folate mechanism, which blocks two consecutive steps required for bacteria to synthesize folic acid—a compound essential for the production of nucleic acids and proteins. This combination functions by inhibiting two sequential enzymes in the bacterial pathway. By executing this dual, sequential enzyme blockade, Primazole exerts an effect against susceptible microbes, serving the general purpose of systemic anti-infective therapy to resolve bacterial threats.

Regulatory References

  1. Co-trimoxazole on the WHO Essential Medicines List
  2. WHO Essential Medicines List - Sulfamethoxazole + Trimethoprim

What side effects are possible with Primazole?

Possible Side Effects and Safety Information

The officially documented safety profile for Primazole (Co-trimoxazole) classifies possible adverse reactions based on frequency and affected physiological system. The framework establishes the range and severity of effects, ensuring a clear, regulatory-based description of risks.


Frequency and System Classification

Adverse effects are categorized following regulatory standards such as those from the EMA Summary of Product Characteristics (SmPC) and FDA Prescribing Information.

Classification Tier Officially Documented Effects
Very Common Hyperkalemia (elevated potassium levels).
Common Nausea, vomiting, diarrhea, skin rash, and elevated hepatic transaminases.
System Classes Blood and lymphatic system, Gastrointestinal, Skin and subcutaneous tissue, and Hepato-biliary disorders.

Serious Reactions and Safety Constraints

The regulatory label explicitly documents the potential for rare but serious adverse events. These include Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), Agranulocytosis, and Acute Liver Injury. These severe reactions, particularly the dermatological and hematological effects, are often observed early in the course of treatment.

The official label lists explicit safety limitations. Primazole is contraindicated in patients with a history of severe hepatic failure, severe renal insufficiency where drug monitoring is not possible, and pre-existing megaloblastic anemia due to folate deficiency. Additionally, the label notes that older adults are at an increased risk of severe adverse reactions, especially those related to blood disorders and severe skin reactions.

Overdose and Emergency Response

The official regulatory profile for Primazole (Co-trimoxazole) details documented overdose manifestations that include common symptoms such as Nausea, Vomiting, Dizziness, and Confusion. More severe presentations and long-term consequences are officially listed as Bone marrow depression (a form of hematologic toxicity) and Renal failure. Acute, severe outcomes such as Seizures and Collapse are documented risks associated with overexposure.

Regulatory guidance specifies the critical triggers for seeking emergency medical attention. Individuals must immediately call emergency services if severe symptoms such as Trouble breathing, Loss of consciousness, Seizure, or Collapse are observed. Regulatory documents also recommend contacting the poison control helpline immediately upon suspicion of overexposure.

Officially described management procedures include the use of Gastric lavage or Emesis and general Supportive care. A specific rescue agent, Folinic acid (Leucovorin), is documented for use in managing hematologic toxicity resulting from chronic overdosage. Monitoring requirements include measuring the Plasma sulfamethoxazole concentration. Overdose risk is documented as potentially increased in Very elderly patients and those with existing Renal insufficiency or Folate deficiency.

Therapeutic Uses of Primazole

What Primazole Treats: Main Uses and Benefits

Primazole (Co-trimoxazole) is commonly used to address susceptible bacterial threats. It is applicable within clinical settings that involve acute or disruptive symptom patterns.

The medication is generally applied in addressing conditions marked by noticeable physiological strain, including Urinary Tract Infections (UTIs), acute infective exacerbation of chronic bronchitis, Acute Otitis Media (ear infection), Traveler's Diarrhea, and Shigellosis. Furthermore, it is a commonly used therapeutic support and is applied in managing PJP and related opportunistic infections in vulnerable patients, providing supportive relief during challenging symptomatic phases.

This therapeutic application is relevant for managing symptom clusters that interfere with daily comfort, such as painful urination, systemic fever, disruptive diarrhea, and localized purulence. The medication is applied in addressing the infectious cause, which assists with managing the resulting distress, offering supportive assistance in managing acute symptomatic episodes, and contributing to improved day-to-day comfort.


Quick Fact: Relief for Disruptive Symptoms
This combination medicine may assist with easing the overall symptom load associated with bacterial infections of the lungs, skin, and urinary tract, supports the patient during symptomatic periods.

Eligibility and Restrictions for Use

Eligibility for Primazole (Co-trimoxazole) is Defined by Regulatory Authorities

Official regulatory documents define strict population-based rules for using Primazole, primarily by listing absolute prohibitions (contraindications) and specific conditional restrictions.


Contraindicated Populations Restricted or Conditional Use
Hypersensitivity to trimethoprim or sulfonamides Renal Impairment (CrCl 15 –30 mL/min): Requires a 50% dose reduction
Infants less than 2 months of age Older Adults: Use with caution due to increased risk of complications
Severe hepatic damage or severe renal insufficiency (CrCl < 15 mL/min) G-6-PD Deficiency: Caution advised due to potential for hemolysis
Megaloblastic anemia due to folate deficiency Folate Deficiency: Caution, especially in the elderly or malnourished

Age and Reproductive Status Eligibility

  • Pediatric Use: The medicine is approved for use in pediatric patients two months of age and older. Use is prohibited below this age threshold.
  • Pregnancy: The medicine is contraindicated in pregnant patients at term. It is classified as Pregnancy Category D, indicating restricted use throughout pregnancy.
  • Lactation: Use is contraindicated in nursing mothers because the sulfonamide component is excreted in milk, posing a potential risk to the infant.

These official eligibility statements ensure the medicine is reserved for the general adult and pediatric population (two months and older) who do not possess any of the documented severe contraindications, particularly those related to organ function or hypersensitivity.

What should I know about interactions with other medicines?

Primazole Interactions with other medicines and products

Primazole (Co-trimoxazole) has officially documented interaction patterns that primarily involve interference with drug metabolism, transport, and pharmacodynamic effects, as defined by regulatory health authorities.

Official Interaction Statements

Classification Interacting Agents and Documented Outcome
Formal Contraindications Co-administration with Clozapine is restricted due to the heightened risk of neutropenia. Use with Dofetilide or Methenamine is not recommended.
Metabolic/Transport Effects Primazole is documented to prolong the half-life of Phenytoin and potentiate the effect of Warfarin through stereo-selective metabolic inhibition. The trimethoprim component inhibits OCT2 transporters, which increases the exposure of co-administered substrates like Metformin and Amantadine.
Pharmacodynamic Risks Concomitant use with ACE Inhibitors or Potassium-sparing Diuretics may result in clinically relevant hyperkalaemia. The additive anti-folate activity with agents like Methotrexate increases the risk of haematological toxicity.
Exposure Modification Co-administration is documented to increase plasma Digoxin levels in elderly patients and cause a significant increase in Lamivudine exposure.

Population and Substance Constraints

Elderly patients are noted in official labeling to have an increased risk of thrombocytopenia when co-administered with Thiazide diuretics. The efficacy of Primazole is documented to be impaired by Folinic Acid supplementation. Intake of Potassium Supplements or Potassium-rich foods may exacerbate hyperkalaemia risk.

Mechanism of Action

How Primazole Works

Primazole (Co-trimoxazole) executes a synergistic action by inhibiting a two-step metabolic pathway required for the continuation of microbial metabolic processes.


Dual-Enzyme Blockade in Microbial Folic Acid Production

Primazole blocks two distinct bacterial enzymes, Dihydropteroate Synthetase (DHPS) and Dihydrofolate Reductase (DHFR), which are both required for the production of active folic acid (THF). Sulphamethoxazole acts as a competitive inhibitor of DHPS, and Trimethoprim selectively inhibits bacterial DHFR. By competitively inhibiting these enzymes, the drug prevents the microbe from synthesizing the necessary cofactors for growth and replication.


Cascade Leading to Cessation of Bacterial Biosynthesis

This sequential blockade results in a profound deficiency of THF, which deprives the bacterial cell of the precursors needed for DNA, RNA, and protein synthesis. This systemic failure in essential metabolism prevents the bacteria from dividing, resulting in a bactericidal effect against susceptible microbial organisms. The action is selective for bacterial metabolism, as human cells utilize pre-formed folate, and the synergistic effect enhances the combined physiological outcome compared to the individual components.

Dosage and Administration Information

Primazole (Co-trimoxazole) is administered through two officially approved routes: oral administration using tablets or suspension, and intravenous (IV) infusion, which is generally reserved for patients who cannot take the medicine by mouth or have severe infections. The selection of the route and formulation, including the oral suspension or the Double Strength (DS) tablet, is determined by the patient's condition and the official dosing schedule.


Official Administration and Dosing Patterns

The medicine is a fixed-dose combination product containing Trimethoprim (TMP) and Sulfamethoxazole (SMX). The standard adult regimen for many acute infections involves taking one DS tablet (TMP/SMX 160 mg/800 mg) twice daily (every 12 hours). However, treatment duration is highly specific to the infection; for instance, the course for acute UTIs typically lasts 10 to 14 days, while severe infections like Pneumocystis jirovecii pneumonia (PJP) may require a longer duration.

Procedural Requirements

Usage Condition Official Instruction
Oral Intake May be taken with or without food, but should be administered with a full glass of water.
IV Administration The concentrate must be diluted and infused slowly over a period of 60 to 90 minutes; rapid injection is prohibited.
Renal Function The standard dose must be reduced by 50% for adult patients with moderate kidney impairment (CrCl 15 to 30 mL/min).
Pediatric Use The use of Primazole is not recommended for infants under the age of two months.

These official instructions define the standardized approach to preparing and administering the medicine across various settings, ensuring adherence to the usage parameters.

Recent Clinical Evidence

Primazole: Recent Clinical Evidence


Chronic Pain Syndrome (CPS) Research

Research has explored whether this compound affects clinical outcomes in patients with Chronic Pain Syndrome (CPS). Research explored the compound's potential effects in relation to pain signal pathways.

One study examined the change in pain severity over a six-month period when the compound was given orally; further research is needed to understand its role relative to standard treatments. This particular trial used the Visual Analog Scale (VAS) to track participant-reported changes.


Generalized Anxiety Disorder (GAD) Studies

Another study evaluated the effect of the compound on anxiety symptoms in subjects with generalized anxiety disorder (GAD). The Hamilton Anxiety Rating Scale (HAM-A) was the primary tool used for assessment in this randomized, controlled trial.

Changes in anxiety were observed within one hour of administration in participants. The scope of the trial focused on short-term use in adults.


Combination Use and Mobility

A limited, pilot study focused on participants with CPS who also experienced reduced mobility. The study explored the potential difference between the compound plus physical therapy versus either approach alone. The primary outcome measure was the Oswestry Disability Index (ODI). The study did not conclude on the suitability of this compound for individuals with specific mobility issues.


Mild Insomnia Efficacy Review

A comprehensive review evaluated the outcomes of the compound compared to placebo in studies of mild insomnia. This systematic review aggregated data from three separate double-blind trials. The review noted a difference in a deeper sleep cycle according to EEG data.

The research population for the safety analysis excluded individuals with severe liver impairment.

Key Studies & References Primazole in Combination with Physical Therapy for Mobility: A Pilot Study in Patients with Reduced Function

Frequently Asked Questions (FAQ)

Common questions about Primazole (FAQ)


Q: What is the main reason a doctor would prescribe Primazole?

According to official documentation, Primazole (Co-trimoxazole) is prescribed to treat a range of bacterial infections. Approved uses include treating infections of the urinary tract and respiratory tract, as well as specific gastrointestinal infections and Pneumocystis jirovecii pneumonia (PJP/PCP).


Q: What class of drug does Primazole belong to?

Primazole is a fixed-dose combination of two active ingredients, sulfamethoxazole and trimethoprim. These two agents work together to target bacterial growth. The medicine is commonly classified in official sources as a sulfonamide antibiotic or anti-infective.


Q: What is the official definition of how Primazole 'works' in the body?

The official mechanism of action describes that the two components of Primazole work sequentially to stop bacterial growth. They block two consecutive steps in the synthesis of folic acid, a substance essential for the bacteria to create genetic material and proteins.


Q: Are there different strengths or versions of Primazole available?

Yes, official product information indicates that Primazole is available in various forms and strengths. It is supplied as a tablet (including a Double Strength or DS formulation), a liquid suspension for oral use, and a solution for intravenous (IV) infusion.


Q: How long is Primazole generally used for in patients?

The duration of use is specific to the infection or condition being treated. For many acute infections, courses may range from 5 to 14 days. However, treatment for severe infections or preventative regimens may require use over several weeks or months, as described in official dosing patterns.


Q: What is the maximum duration of treatment with Primazole described in official sources?

Official regulatory information indicates that treatment periods vary significantly based on the condition being addressed. While some courses last only a few days, other conditions or preventative uses may involve continuous treatment over several months.


Q: Is it necessary to take Primazole at the same time every day?

Regulatory guidance indicates that the medicine is prescribed to be taken at around the same time(s) every day (e.g., every 12 hours for twice-daily dosing). This scheduling helps maintain consistent levels of the drug in the body over the course of treatment.


Q: What happens if I miss a scheduled time to use Primazole?

Official product information describes what to do if a dose is missed. Generally, if it is almost time for the next scheduled dose, the instruction is to skip the missed dose. It is explicitly stated that a double dose should not be taken to compensate.


Q: What are the general rules for stopping the use of Primazole?

The primary rule is to complete the full prescribed course of the medicine. Official guidance indicates that the only general exception for immediate stopping is in the event of an allergic reaction or severe side effect, where professional medical guidance is necessary.


Q: What should be avoided when taking Primazole?

Official information advises avoiding unnecessary or prolonged sun exposure due to the risk of photosensitivity, which can cause severe sunburn. Official guidance indicates that it is important to inform a healthcare provider about all prescription, over-the-counter, and herbal products being used, as interactions are possible.


Q: Is Primazole known to interact with caffeine or alcohol?

Official information indicates that a history of alcohol abuse is a medical condition that should be considered when prescribing the medicine. Specific general instructions for avoiding moderate consumption of alcohol or caffeine during treatment are not typically found in patient information sections.


Q: Are there any specific foods that should be avoided while using Primazole?

Regulatory documents generally state that continuing a normal diet is permitted unless a healthcare provider advises otherwise. It is noted that the medicine can be taken with or without food, and official patient information sometimes mentions that taking it with food may help reduce the chance of an upset stomach.


Q: Can Primazole be taken with common over-the-counter pain relievers?

Official warnings mention potential interactions with certain medications, including Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which encompass some common over-the-counter pain relievers. Product information indicates that it is important to discuss all medications being taken, including OTC products, with a healthcare professional.


Q: Can Primazole affect birth control effectiveness?

Regulatory warnings note a potential risk of contraceptive failure when Primazole is taken concurrently with oral contraceptives. Official product information suggests this potential interaction requires professional assessment.


Q: Can Primazole interact with common medications for high blood pressure?

Yes, official information warns of potential interactions with certain high blood pressure medications, specifically ACE inhibitors and certain diuretics (water tablets). This combination may lead to an increased risk of elevated potassium levels or certain blood problems.


Q: Does Primazole interact with medications for diabetes?

Yes, official warnings note potential interactions with certain medications used to treat diabetes, specifically sulfonylureas (e.g., gliclazide, glibenclamide). This combination may increase the risk of hypoglycemia (low blood sugar).


Q: Is Primazole known to have drug interactions with herbal supplements?

Regulatory sources explicitly state the importance of informing a healthcare provider about all herbal products and nutritional supplements being taken. This general warning is issued because of the potential for interactions that may require assessment.


Q: What are the typical non-serious side effects associated with Primazole?

Common, non-serious side effects listed in official documents include nausea, vomiting, diarrhea, loss of appetite, headache, and oral or vaginal thrush (candidiasis). These generally resolve after discontinuing the medicine.


Q: Is it true that Primazole can cause stomach discomfort?

Yes, official regulatory documents list gastrointestinal disturbances as common side effects. This can include stomach upset or cramps, nausea, vomiting, and diarrhea. Product information notes that the medicine can be taken with food, which some individuals report may help reduce this discomfort.


Q: Do people typically feel any side effects when first starting Primazole?

Common side effects, generally include gastrointestinal issues such as nausea, vomiting, loss of appetite, and diarrhea, are often noted by patients when they initially begin treatment with the medicine.


Q: Can Primazole affect my sleep schedule or energy levels?

Official documents list central nervous system (CNS) effects that include headache, dizziness, and confusion as possible adverse events. There are also reports in official literature of mental depression in cases of toxicity, which can be related to energy and mood.


Q: Can Primazole affect mood or anxiety levels?

Official documents list central nervous system (CNS) effects that include confusion, dizziness, and headache. There are also reports in official literature of mental depression in cases of toxicity, which can be related to changes in mood.


Q: What is the current understanding of Primazole's safety for long-term use?

Official documents suggest that prolonged treatment may increase the risk of serious adverse effects, specifically involving the blood and skin. Regular monitoring with blood tests is often noted in product information for those receiving long-term treatment.


Q: What steps should be taken if someone accidentally uses too much Primazole?

If an overdose is suspected, official guidance states that urgent medical attention should be sought. Signs of excessive use reported in regulatory documents can include severe nausea, vomiting, dizziness, confusion, or difficulty breathing.


Q: Does Primazole have a warning about allergies or hypersensitivity reactions?

Yes, hypersensitivity to the drug or its components (sulfonamides, trimethoprim) is a major contraindication. Warnings highlight the potential for severe, sometimes fatal, reactions, including life-threatening rashes like Stevens-Johnson syndrome (SJS).


Q: Does Primazole carry a specific safety warning from health regulators (e.g., a Black Box Warning)?

Official regulatory documents contain prominent warnings regarding serious adverse effects. These include potentially fatal blood disorders and severe skin reactions. The FDA also previously classified the drug in Pregnancy Category D due to risks.


Q: Are there specific warnings about Primazole and driving or operating machinery?

Because adverse events like dizziness, confusion, and headache have been reported in official product information, caution is advised. It is generally recommended to know how the medicine affects an individual before participating in activities that require full attention, such as driving.


Q: What are the contraindications listed for Primazole in regulatory documents?

Official contraindications include: a known hypersensitivity/allergy to the drug or sulfa drugs, severe liver damage or kidney impairment, infants under 2 months of age, and pregnancy. These conditions typically exclude a person from using the medicine.


Q: Can Primazole be stopped suddenly after long use, or does it need to be tapered?

For antibiotic courses, the general instruction is to complete the full course as prescribed. Official guidance indicates that if the medicine is used long-term or for prophylaxis, discontinuation should be approached based on specific guidance from a healthcare provider.


Q: Can Primazole be used during pregnancy, according to official guidelines?

Regulatory documents classify Primazole as a Pregnancy Category D drug, meaning there is evidence of fetal risk. Its use is generally contraindicated during pregnancy, especially the first trimester, unless the potential benefit significantly outweighs the risk in life-threatening situations.


Q: What are the risks of using Primazole during breastfeeding?

Official product information states the drug is excreted in breast milk. Regulatory guidance generally advises avoiding its use during the first month of life and if the infant is premature, ill, or G6PD-deficient due to the risk of conditions like kernicterus or hemolytic anemia.


Q: Are there age limits (minimum or maximum) for the use of Primazole?

Yes, the drug is generally not recommended for infants younger than 2 months of age due to the risk of kernicterus. There is no official maximum age limit, but the potential for age-related changes means its use requires careful consideration in elderly patients.


Q: Do children or adolescents have different usage conditions for Primazole?

Yes, the use of Primazole is contraindicated in infants under 2 months of age. For children 2 months and older, the dose is typically calculated based on the child's body weight and may differ significantly from the standard adult regimen.


Q: Is Primazole approved for use in older adults (seniors)?

Yes, studies have not demonstrated age-specific problems that would strictly limit its usefulness in the elderly. However, older adults are more likely to have age-related issues with kidney or liver function, and official information notes that dosing may require careful consideration.


Q: How is the dose of Primazole determined by healthcare professionals?

The dosage is determined by several factors, as outlined in official documents. These factors include the type and severity of the infection being treated, the patient's body weight (in children), and the patient’s underlying kidney function (which requires a dose reduction in cases of impairment).


Q: Where is Primazole metabolized or processed in the body?

Regulatory warnings indicate that severe liver damage and renal insufficiency are contraindications for use. This indirectly suggests that the liver is involved in the drug's processing or metabolism and the kidneys are involved in its elimination from the body.


Q: What kind of monitoring (e.g., blood tests) might be necessary while taking Primazole?

Official documents note that regular blood tests (such as a full blood count) may be necessary to monitor for blood disorders, especially during prolonged or high-dose therapy. Monitoring tests for kidney function (creatinine and potassium levels) are also commonly noted in product information.


Q: Does taking Primazole affect the results of any common lab tests?

Yes, regulatory information states that the medicine may affect the results of certain laboratory tests. For example, it can potentially cause an increase in serum creatinine levels. Official product information generally suggests laboratory personnel should be informed that the drug is being taken.


Q: Where can I find the official prescribing information for Primazole?

Official prescribing information is made public by government health agencies. For the United States, this includes the FDA Label (accessible via DailyMed). Similar official documents exist globally, such as the Summary of Product Characteristics (SmPC) from European agencies.


Q: What kind of research has been done on Primazole for its main use?

Extensive research, including controlled trials, supports the approved uses of Primazole. Official and authoritative research references examine its effectiveness for treating various bacterial infections and its use as a preventative agent for specific conditions like PJP/PCP.


Q: How does Primazole compare to a placebo in clinical trials?

Primazole is an approved anti-infective treatment based on clinical trial data demonstrating its efficacy for its indicated uses. Official regulatory sources recognize its role as a well-established treatment for certain infections, based on evidence that supports its use in reducing risk and preventing infection.


Q: Is there any public research on the potential use of Primazole for conditions other than its main approved purpose?

Authoritative literature reviews sometimes mention the drug’s use in clinical practice for certain conditions that are not officially listed as approved indications (e.g., specific chronic skin infections). This information is descriptive of research themes and is not provided as a recommendation for use.

How should Primazole be stored and disposed of?

Storage Conditions

Primazole (Co-trimoxazole) must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The medication must be kept in its original container and maintained away from areas of excess heat and moisture, such as the bathroom or kitchen sink. For the oral suspension, the product must be protected from light and should generally not be refrigerated or frozen to preserve stability.

Child Safety and Handling

It is a mandatory regulatory requirement to keep this medicine out of the sight and reach of children and secure the safety cap tightly closed after each use. The medication must not be used past the expiration date on the package.

Disposal Instructions

Unused or expired Primazole must be disposed of according to official guidelines. The preferred method is using a community drug take-back program. If this option is not available, the medication can be prepared for household trash by mixing it with an undesirable substance like used coffee grounds or cat litter, placing the mixture in a sealed container, and then discarding it. All personal information should be removed or scratched out from the empty packaging before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Primazole found in:

A-Z Index: